Doxorubicin Hydrochloride Injection, Solution
Product Images NDC 63323-101

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 63323-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Dox0c 0000 01)

Chemical structure of doxorubicin hydrochloride, depicting the molecular arrangement of the active ingredient including multiple ring systems, hydroxyl groups, and a hydrochloride component.*

FDA Label Image

Figure-1 (Dox0c 0000 02)

A meta-analysis figure illustrating disease-free survival from six studies comparing Doxorubicin-based treatment to CMF. The chart shows individual trial hazard ratios with 95% confidence intervals, plotted along a horizontal axis where values less than 1 indicate Doxorubicin is better than CMF and values greater than 1 indicate worse outcomes. A diamond shape summarizes the combined results, and a boundary of non-inferiority with CMF is indicated.*

FDA Label Image

Figure-2 (Dox0c 0000 03)

A forest plot chart titled 'Meta-analysis of Overall Survival' showing hazard ratios with 95% confidence intervals for six studies comparing Doxorubicin-based treatment to CMF. The plot includes study names on the y-axis and hazard ratio values on the x-axis, with a summary diamond for the combined effect.*

FDA Label Image

Logo (Dox0c 0000 04)

FDA Label Image

Vial (Dox0c 0000 05)

Label for Doxorubicin Hydrochloride Injection, USP, 2 mg/mL, in a 5 mL single-dose vial. The label states it is for intravenous use only and is preservative free. The product is labeled by Fresenius Kabi USA, LLC and is prescription-only.*

FDA Label Image

Pbox (Dox0c 0000 06)

Label of Doxorubicin Hydrochloride injection, USP, showing strength of 10 mg per 5 mL (2 mg per mL). The label states it is for intravenous use only, preservative free, and Rx only. It is packaged as a 5 mL single dose vial by Fresenius Kabi USA, LLC.*

FDA Label Image

Vial (Dox0c 0000 07)

Label for Doxorubicin Hydrochloride Injection, USP, showing strength of 200 mg per 100 mL (2 mg per mL). The label states intravenous use only, preservative free, 100 mL multiple dose vial, and Rx only. No manufacturer name is visible on this label image.*

FDA Label Image

Pbox (Dox0c 0000 08)

Label for Doxorubicin Hydrochloride Injection, USP, 2 mg/mL (200 mg per 100 mL) intravenous solution. The label states 'Preservative free' and is marked for prescription use only. The vial is a 100 mL multiple dose vial from Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.